Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 1387 Neoplasms 1164 Colorectal Neoplasms 624 Lung Neoplasms 559 Prostatic Neoplasms 538 Carcinoma, Non-Small-Cell Lung 443 Carcinoma, Hepatocellular 296 Stomach Neoplasms 272 Pancreatic Neoplasms 270 Colonic Neoplasms 264 Ovarian Neoplasms 230 Head and Neck Neoplasms 228 Rectal Neoplasms 221 Melanoma 215 Multiple Myeloma 202 Uterine Cervical Neoplasms 198 Lymphoma 195 Leukemia 193 Precursor Cell Lymphoblastic Leukemia-Lymphoma 191 Neoplasm Metastasis 178 Carcinoma, Renal Cell 177 Esophageal Neoplasms 173 Brain Neoplasms 173 Leukemia, Myeloid, Acute 158 Urinary Bladder Neoplasms 138 Recurrence 123 Polycystic Ovary Syndrome 122 Liver Neoplasms 118 Hematologic Neoplasms 117 Endometrial Neoplasms 107

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × DILI × Clear all

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡